US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
ヨーロッパ
EU
Roche Bobois SA (RBO) 銘柄情報

Roche Bobois SA (RBO)

25.10

-0.10

(-0.40%)

終了 6月4日 12:30AM

Roche Bobois SA (RBO) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

25.10

( -0.40% )

買値

25.10

売値

25.30

出来高

3,033

25.00 日の範囲 25.30

22.80 52 週間の範囲 41.30

時価総額

前日終値

25.20

始値

25.30

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

1,131 €

発行済株式数

10,082,178

配当利回り

0.8 (3.08%)

PER

25.43

1 株当たり利益 (EPS)

1

歳入

402.52M

純利益

10.07M

Roche Bobois S.A. engages in the furniture design and distribution business in France, Japan, and internationally. The company offers living room products, such as sofas and sofa beds, coffee tables, armchairs, cocktail tables, TV units, bookcases, cabinets, consoles, and occasional furniture; dinin... Roche Bobois S.A. engages in the furniture design and distribution business in France, Japan, and internationally. The company offers living room products, such as sofas and sofa beds, coffee tables, armchairs, cocktail tables, TV units, bookcases, cabinets, consoles, and occasional furniture; dining room products, including chairs, stools, benches, dining tables, and dining room storage products; bedroom products comprising beds, wardrobes, and other bedroom furniture products; outdoor furniture products, including sofas, armchair, and decoration; desks and office chairs; and other products, including lights, cushions, rugs, mirrors, and home furnishings, as well as other furniture products. It serves its products under the Roche Bobois and Cuir Center brand names. The company was formerly known as Furn-Invest S.A.S. Roche Bobois S.A. was founded in 1960 and is headquartered in Paris, France. 詳細を表示

セクター

Consumer Discretionary

業界

Home And Homeware

ウェブサイト

www.roche-bobois.com

本社

Paris, France

設立

1960

Roche Bobois SA is listed in the Consumer Discretionary sector of the ユーロネクスト with ticker RBO. The last closing price for Roche Bobois was 25.20 €. Over the last year, Roche Bobois shares have traded in a share price range of 22.80 € to 41.30 €.

Roche Bobois currently has 10,082,178 shares in issue. The market capitalisation of Roche Bobois is 253.06 € million. Roche Bobois has a price to earnings ratio (PE ratio) of 25.43.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-1.2	-4.56273764259	26.3	26.3	25	1083	25.35064635	DE
4	-0.7	-2.71317829457	25.8	27.5	25	1428	26.05629255	DE
12	-0.8	-3.0888030888	25.9	27.5	22.8	1254	25.55072406	DE
26	-10.9	-30.2777777778	36	36.2	22.8	1655	27.60661679	DE
52	-15	-37.4064837905	40.1	41.3	22.8	1246	29.93209766	DE
156	-18.8	-42.8246013667	43.9	55.2	22.8	1245	40.56193222	DE
260	3.6	16.7441860465	21.5	55.2	21.4	1437	37.34519062	DE

RBO - Frequently Asked Questions (FAQ)

What is the current Roche Bobois SA share price?

The current share price of Roche Bobois SA is 25.10 €

How many Roche Bobois SA shares are in issue?

Roche Bobois SA has 10,082,178 shares in issue

What is the market cap of Roche Bobois SA?

The market capitalisation of Roche Bobois SA is EUR 253.06M

What is the 1 year trading range for Roche Bobois SA share price?

Roche Bobois SA has traded in the range of 22.80 € to 41.30 € during the past year

What is the PE ratio of Roche Bobois SA?

The price to earnings ratio of Roche Bobois SA is 25.43

What is the cash to sales ratio of Roche Bobois SA?

The cash to sales ratio of Roche Bobois SA is 0.64

What is the registered address of Roche Bobois SA?

The registered address for Roche Bobois SA is 18 rue de Lyon, Paris, Ile-de-France, 75012

What is the Roche Bobois SA website address?

The website address for Roche Bobois SA is www.roche-bobois.com

Which industry sector does Roche Bobois SA operate in?

Roche Bobois SA operates in the Home and Homeware sector

Kool Aid Man

Kool Aid Man 7分前

Who owns those 510 million shares? All those 'consultants' issued shares in Q2-Q3 2025?

3331

The IPO Trap vs. The Ground Floor: Why BIEL is the True Venture Capital Play
?We’ve all seen the script play out with the massive tech giants. ?By the time companies like SpaceX, OpenAI, or Anthropic finally decide to go public, the real money has already been made. They spend years raised a

Slojab

Cute. Someone didn't want PNXP to close in the trips so they splurged to buy 100 shares at .00108 9 minutes before the close. That's not even 11 cents! Now, who could that be? 🤔

Volume: 3,329,159

dinogreeves

dinogreeves 14分前

Now that the Delfin Midstream Final Investment Decision (FID) is officially complete, the project is expected to trade publicly by utilizing theglobe.com, inc. (TGLO) as its public vehicle through a structured reverse merger.Because Delfin has meticulously maintained and funded this SEC-reporting pu

sentiment_stocks

sentiment_stocks 19分前

Yes, but that Stupp result would have included a decent number of IDH mutated patients who live longer and are no longer considered GBM. The question now is, what is the mOS for IDH wild type GBM patients only?

Slojab

Slojab 19分前

MM signals. Lord help us. 🥱

dinogreeves

dinogreeves 19分前

Yes, the addition of Global Infrastructure Partners (GIP), a powerhouse asset manager backed by BlackRock, fundamentally changes the outlook for Delfin Midstream and by extension, TGLO.This partnership transitions the project from a highly speculative penny-stock narrative into a heavily institution

nowwhat2

nowwhat2 20分前

Boy, that was really sumpthin' huh ?

https://investorshub.advfn.com/uimage/uploads/2026/6/3/gkubkbtc_june_3_5d_1215_OHTL66666__PENCIL_BELL.jpg

https://investorshub.advfn.com/uimage/uploads/2026/6/3/bocvjbtc_june_3_5d_7pm_pencil.jpg

Biotrader23

Biotrader23 22分前

spoke today with Alex Arzeno of SCR Partners whom Terrie K (or jing ma) hired for IR.. dude seems to have decent background in real estate biz namely REITs but complete nube in biotech/healthcare.. they never served any publicly traded biotechs so cant really blame them, they wouldnt say no to new c

norisknorewards

norisknorewards 23分前

Maybe nwbo displayed (the misunderstood) pfs endpoint first (before the OS result), on purpose, on that Mulholland slide deck on that fateful day.

I think, in my opinion, dilution is the last thing LP is worried about, because maybe, maybe, she actually did foresee how this would play

lakers17

lakers17 24分前

Many reasons. Human nature, lack of money, jealousy of others having more success than they do and many more reasons. Like I always say, trust the process. It's clear what is being developed in the US. Clarity is important but so is getting crypto in the Federal Reserve. That's just the US. 21

Investor082

Investor082 24分前

There were a lot of dreamers like you pre TLD and JAMA expecting $20+ share price in 2022 and had already made plans on spending it. Make sure LP and her financiers don’t take you for a ride while you’re en-route to the beach. That scream could end up being in anguish, LOL! ;)

Gravedigger1

Gravedigger1 25分前

Morality?I’m judging your use of time - entirely your choice and on full display - while you have a claim to incredible experience, insight, knowledge, foresight(!!!), and pity the rest of the investment world.
Newsflash:Some people make money and don’t need to “guard” a stock daily.
T

axelvento

axelvento 26分前

New cancer vaccine delivers stunning result against one of the deadliest skin cancers

KEYNOTE-942
After about a five-year follow-up, the combo drug was found to reduce the risk of melanoma recurrence or death by 49% compared to pembrolizumab alone.

According to

TexasMarvL

TexasMarvL 26分前

CEO Kimberly Ann.
She definitely has a lot of confidence. I want to hang on just to she if she can deliver.

https://youtu.be/htDcyIyYums?si=7RxZ3lRhGaQu-PQE

chen1992

chen1992 28分前

The fact that we aren’t talking about FID anymore and now all eyes are on the 8-K is surreal. It feel dream like after so many letdowns

douginil

douginil 31分前

Hmmmm

I wonder if our process into metals and oxides gets us into 5 nine purity.

Investor2014

Investor2014 31分前

Ah, OhSay’s older and wiser brother finally arrives, very late in the Anavex saga and, unlike his younger brother, having actually made money from his $AVXL insights. That apparently now qualifies you to lecture others on morality and judge message-board posters with unwavering conviction.

Investors3

Investors3 31分前

I agree with you. If BTC was a good investment at a higher price, then why not buy more, when it is down? I actually find my crypto investments much more exciting than my stock investments. And being able to buy when i want (24 x7) is also a nice benefit. Yes, i don't understand why some people cele

georgejjl

georgejjl 32分前

New Treatment for Alzheimer’s and Parkinson’s Discovered in JapanResearchers use a vitamin K and vitamin A hybrid to transform stem cells into functional neurons, offering a potential path to restoring lost brain function.

https://www.inc.com/lucia-auerbach/future-of-brain-health-how-

ZenChimera371

ZenChimera371 33分前

So, a couple things here.

1. There seems to be inconsistency in the filing regarding communication about convertible debt reduction. They claimed 1 million reduction but I am not seeing that reduction noted in the actual filings for that time period.

2. How are they avo

Biotrader23

Biotrader23 33分前

call it BS since they signed off on the CSR

SemperFITrader

SemperFITrader 35分前

FMc, Both CTBVEAG and CHM are under Licensing, how many times do I have to say that, nothing else really has to be stated past that. CTA data is meaningless since it relates to Clinical Trial Acceptance. Marketing Authorisation under Licenses is the key to both meetings period.
I asked you

Split T

Split T 35分前

Wow, LIBOR and Ezell litigation ends and some of you think that the price is dropping because sellers are pulling listings..lol. you might ought to rethink why the shorts are buying hand over fist.

Biotrader23

Biotrader23 38分前

Been holding sig AVXL position for the last 5 years, regulatory setbacks are common in biotech world, some of my best winners had to overcome those..

Since we have no cash/runway issues my biggest worry at the moment is the direction: Jing Ma (aka SPAC queen) firmly in charge, just lo

Antilles Gold (PK)

DJ Americas Oil & Gas To...

Fury Gold Mines

Orpheus Club Wellness Ad

Plurilock Security

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。